What is it about?
High-sensitive thyroglobulin assays allow us to decrease the intensity and frequency of follow-up in those patients having undetectable Tg after primary treatment.
Featured Image
Read the Original
This page is a summary of: Unstimulated high-sensitive thyroglobulin is a powerful prognostic predictor in patients with thyroid cancer, Clinical Chemistry and Laboratory Medicine (CCLM), December 2019, De Gruyter,
DOI: 10.1515/cclm-2019-0654.
You can read the full text:
Contributors
The following have contributed to this page
